Immunic, Inc. (FRA:10VA)
0.5080
+0.0630 (14.16%)
At close: Jan 5, 2026
Immunic Market Cap
Immunic has a market cap or net worth of €68.76 million as of January 9, 2026. Its market cap has decreased by -25.83% in one year.
Market Cap
68.76M
Enterprise Value
39.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.51
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from 215.57M to 68.76M, a decrease of -68.11%. That is a compound annual growth rate of -15.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 68.76M | 25.75% |
| Dec 31, 2025 | 54.68M | -37.16% |
| Dec 31, 2024 | 87.01M | 42.02% |
| Dec 29, 2023 | 61.26M | 5.43% |
| Dec 30, 2022 | 58.11M | -73.69% |
| Dec 31, 2021 | 220.89M | -14.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |